Differentiated Thyroid Carcinoma: The Impact of Initial Surgical Therapy  by Khairy, Gamal A.
117 
 
 
 
Differentiated Thyroid Carcinoma:  
The Impact of Initial Surgical Therapy 
 
Dr. Gamal A. Khairy FRCS, FBS, MS 
 
Associate Professor of Surgery and Consultant Surgeon 
College of Medicine, King Saud University 
Riyadh, Kingdom of Saudi Arabia 
 
 
 
 
 
CLINICAL STUDY 
Abstract 
Objective 
The extent of surgery for differentiated thyroid carcinoma (papillary and follicular) is still 
controversial, extending from simple lobectomy to extensive total thyroidectomy.  The 
objective of this study was to assess the outcome of different types of thyroidectomy in 
patients with differentiated thyroid carcinoma (DTC). 
Methods 
The extent of primary surgical therapy for 428 patients with thyroid lesions who underwent 
surgery, in whom the final diagnosis were confirmed histologically, were reviewed.  Those 
who developed recurrence after surgery were analyzed further. 
Results 
Forty two patients had differentiated thyroid carcinoma. Regarding surgical treatment, 27 
patients had lobectomy and 15 had total thyroidectomy.  Out of six patients who developed 
recurrence, five had lobectomy as initial surgical treatment and one underwent subtotal 
thyroidectomy.  None of the patients in total thyroidectomy group developed recurrence. 
Conclusion  
In the absence of general agreement of the optimal primary surgical therapy for DTC,  our 
data indicate that more extensive surgery has a better outcome and with less recurrence rate. 
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Introduction 
 
hyroid cancer is the most common 
endocrine malignancy, excluding 
ovarian cancer with the highest mortality1.  
About 98% of thyroid cancers ,are of the 
differentiated type2.  Thyroidectomy is the 
primary treatment for patients with 
differentiated thyroid cancers (DTC).  
However, the extent of surgery remains 
controversial with strong support for total 
thyroidectomy and its presumed disease 
control benefits3-7.  In contrast advocates of 
partial thyroidectomies also found 
equivalent disease control but lower hazard 
of parathyroid and recurrent nerve injury8-
10. 
Thus extent of prirmary thyroidectomy for 
patient with DTC remains controversial due 
to lack of prospective randomized 
controlled trials comparing the outcome 
associated with different types of 
thyroidectomies11. 
The aim of the present study was to 
compare the outcome of different types of 
thyroidectomies for patients with malignant 
thyroid lesions treated surgically at King 
Khalid University Hospital, Riyadh. 
 
Materials and Methods 
 
This is a retrospective study of consecutive 
patients with different thyroid disorders 
seen at surgical clinics at King Khalid 
University Hospital from January 1990 to 
December 1997.  The final histological 
diagnosis and the extent of surgical therapy 
of 428 patients who underwent surgery 
were reviewed.  Only patients who 
underwent surgery and their final 
histological diagnosis could be traced were 
included in the study.  Patients with DTC 
(Papillary and follicular) were further 
analyzed, focusing on those who developed 
recurrence after surgery, clinically as well as 
cytological confirmation.  The data were 
analyzed using SPSS version 12 (Statistical 
package of software), percentages for 
different types were obtained using 
frequency table.   
 
Results 
 
A total of 512 medical records of patients 
with thyroid disorders were reviewed.  
Eighty four patients were excluded from the 
study; 73 patients did not have any surgical 
intervention and in 11patients histological 
results could not be traced.  In the remaining 
428 patients (study population), there were 
390 females and 38 males with a mean age of 
41.7 (range 12-70) years.  Forty eight patients 
(11.2%) had malignant thyroid lesions in the 
final histological diagnosis (Table 1), 36 
(75%) had papillary carcinoma and 6 (12.5%) 
follicular type (Table 2).  Regarding surgical 
treatment offered to those who had 
malignant thyroid lesions, 27 patients had 
lobectomy and 15 had total thyroidectomy 
(Table 3).  Six patients (12.5%) developed 
recurrence, none of them had positive 
family history, five had lobectomy as their 
initial surgical treatment and one had 
subtotal thyroidectomy.  None of those who 
had total thyroidectomy as their initial 
surgical therapy developed recurrence. 
 
 
Table 1: Paraffin section results of patients with thyroid lesion who underwent surgery 
Nodular 
hyperplasia 
N (%) 
Adenoma 
N (%) 
Malignant 
N (%) 
Others (Grave’s disease, cyst, 
thyroiditis)  
N (%) 
Total 
212 (49.5) 63 (14.7) 48 (11.2) 105 (24.6) 428 (100%) 
 
 
T 
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 Table 2: Different types of thyroid malignant lesions   
Papillary 
Carcinoma 
N (%) 
Follicular 
carcinoma 
N (%) 
Anaplastic carcinoma 
N (%) 
Lymphoma 
N (%) Total 
36 (75) 6 (12.5) 2 (4.2) 4 (8.3) 
 
48 
(100%) 
 
 
 
Table 3: The types of initial surgical therapy for 48 patients with thyroid malignancy with the 
recurrence in each type 
Type of Surgery No. of Patients Recurrence (N) 
Lobectomy 27 5 
Subtotal thyroidectomy 3 1 
Near total thyroidectomy 3 - 
Total thyroidectomy 15 - 
TOTAL 48 6 
 
Discussion 
 
The annual incidence of thyroid carcinoma 
varies worldwide from 0.5 to 10 per 100,000 
population12.  The two most common types 
of thyroid cancer, papillary and follicular 
thyroid cancer, together termed 
differentiated thyroid cancer (DTC), 
comprise the majority of thyroid cancers 
and have the best prognosis13. 
In Saudi Arabia, a substantial rise in 
incidence of thyroid carcinoma has been 
observed14.  Other locoregional data showed 
similar changes15. This is in line with data 
from other parts of the world showing the 
same rise in the number of new cases of 
(DTC) in the last decades16. 
In the current series, 36 patients were 
having papillary carcinoma and six had 
follicular type.  The extent of primary 
surgical resection for well-differentiated 
thyroid cancer remains controversial. As to 
the surgical treatment offered to the patients 
in the present series, 27 patients had 
lobectomy and 15 had total thyroidectomy  
 
(Table 3).  Some surgeons advocate 
unilateral lobectomy on the affected side, 
claiming no difference in survival and with 
decreased morbidity when compared to 
bilateral thyroidectomy17, 18.  Others 
recommended a near-total thyroidectomy, 
removing all the affected lobe, isthmus and 
part of the contralateral lobe claiming that 
there is a decreased rate of local recurrence 
when compared to patients who have 
undergone a unilateral procedure19,20.  
Others prefer total thyroidectomy as 
complete removal of the gland facilitates the 
detection and ablation of metastatic disease 
with radioactive iodine21-24. In the current 
series, 36 patients were having papillary 
carcinoma and 6 had follicular type (Table 
2). More extensive surgery was 
recommended for papillary thyroid 
carcinoma by physicians because of the 
nature of multifocal lesions in this type of 
thyroid cancer.  The incidence of multiple 
thyroid involvement in papillary thyroid 
carcinoma varies widely from 18-87.5%25-27. 
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Early reports26,28, found multiple thyroid 
involvement to be of prognostic value in 
increasing the risk of recurrence and 
mortality, where as others suggested that it 
was not associated with higher recurrence 
rate29.  In follicular carcinoma, the surgeon 
may resort to completion thyroidectomy 
after an initial thyroid lobectomy.  This is 
because, a preoperative fine needle 
aspiration biopsy or intraoperative frozen 
section frequently fail to diagnose follicular 
carcinoma of the thyroid gland30,31. Clark 
reported that 29% of patients undergoing 
total thyroidectomy for DTC had already 
undergone a previous thyroid operation32.  
Others also concluded that once the 
diagnosis of DTC was made in one lobe, 
completion thyroidectomy should be 
considered33.  In this series, staging or risk 
group classification was not a criterion to 
choose the type of surgery offered to the 
patients. Many surgeons  consider  the  risk 
 group classification (AMES, AGES etc.) as a 
criterion before completion thyroidectomy is 
recommended34-36. 
In the current series, six patients (12.5%) 
developed recurrence, five had lobectomy as 
their initial surgical treatment and only one 
had subtotal thyroidectomy.  None of those 
patients who had total thyroidectomy as 
their initial surgical therapy developed 
recurrence.  The reported recurrence rates 
with DTC ranged from 20% to 40%37.  
Although the optimal extent of surgery is 
still debated, our data show a much better 
outcome with more extensive surgery, total 
thyroidectomy, and this is in line with the 
opinion of many previous workers19-24.  
DeGroot and associates24 found lobectomy 
plus at least contralateral subtotal 
thyroidectomy decreased the risk of death in 
patients with tumors larger than 1 cm and 
decreased risk of recurrence among all 
patients.  Mazzaferri37 also had similar 
previous opinion. The main argument 
against performing more extensive surgery 
is higher complication rates, and this seems 
less important nowadays as highly skilled 
surgeons are reporting improved 
complication rates38, 39.  However, in a large 
series40 covering 50 year and 2 institutes, 
more extensive thyroid surgery was not 
clearly beneficial in low-risk or even in high 
risk patients, in addition to being associated 
with increased complications41-43.  The 
debate surrounding the management of 
DTC seems to be fueled further by the fact 
that no prospective randomized trials on 
this subject have been conducted13. 
The author concludes that, although the 
extent of primary surgery for DTC is still 
controversial, more extensive surgery has a 
better outcome, at least regarding recurrence 
rate.  A well-designed prospective study is 
recommended to determine the optimal 
therapy based on cost-to-benefit analysis, 
risk and recurrence rate. 
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